Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Cheminet

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|May 20, 2020
Analysis of Paradoxical Efficacy of Carbapenems against Carbapenemase-Producing Escherichia coli in a Murine Model of Lethal PeritonitisAriane Roujansky, Victoire de Lastours, François Guérin, et al.
British Journal of Haematology|March 25, 2023
Acute chest syndrome in adult patients with sickle cell disease: The relationship with the time to onset after hospital admissionGeoffrey Cheminet, Antoine Brunetti, Djamal Khimoud, et al.
European Journal of Haematology|June 28, 2023
Efficacy of COVID-19 vaccination in adult patients with sickle cell disease during the Omicron wave in FranceJulien Derdevet, Brigitte Ranque, Djamal Khimoud, et al.
British Journal of Haematology|May 27, 2024
Assessment of fatigue in adult patients with sickle cell disease: Use of the functional assessment of chronic illness therapy-Fatigue (FACIT-fatigue) questionnaireGeoffrey Cheminet, Anne Corbasson, Marie Charmettan, et al.
British Journal of Haematology|November 10, 2022
Safety of coronavirus disease 2019 vaccines in 213 adult patients with sickle cell diseaseLaure Joseph, Anne Corbasson, Sandra Manceau, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 2, 2025
Central-venous-catheter-related bloodstream infections in adult patients with sickle cell disease: a retrospective, two-centre studyMatthieu Holub, David Lebeaux, Patrick Grohs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 2023
Nirmatrelvir and Ritonavir Combination in COVID-19 Patients With Advanced Chronic Kidney DiseaseEmmanuel Lafont, Damien Blez, Marc-Antoine Bildan, et al.
La Revue De Medecine Interne|March 19, 2021
[Abnormal urine color assessment: The urine wheel]Edouard Flamarion, Constance Reichert, Caroline Sayegh, et al.
Internal and Emergency Medicine|June 29, 2018
Extreme hypomagnesemia: characteristics of 119 consecutive inpatientsGeoffrey Cheminet, Gabrielle Clain, Anne-Sophie Jannot, et al.
American Journal of Hematology|December 9, 2021
Risk factors for severe COVID-19 in hospitalized sickle cell disease patients: A study of 319 patients in FranceJean-Benoît Arlet, François Lionnet, Djamal Khimoud, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|May 20, 2020
Analysis of Paradoxical Efficacy of Carbapenems against Carbapenemase-Producing Escherichia coli in a Murine Model of Lethal PeritonitisAriane Roujansky, Victoire de Lastours, François Guérin, et al.
British Journal of Haematology|March 25, 2023
Acute chest syndrome in adult patients with sickle cell disease: The relationship with the time to onset after hospital admissionGeoffrey Cheminet, Antoine Brunetti, Djamal Khimoud, et al.
European Journal of Haematology|June 28, 2023
Efficacy of COVID-19 vaccination in adult patients with sickle cell disease during the Omicron wave in FranceJulien Derdevet, Brigitte Ranque, Djamal Khimoud, et al.
British Journal of Haematology|May 27, 2024
Assessment of fatigue in adult patients with sickle cell disease: Use of the functional assessment of chronic illness therapy-Fatigue (FACIT-fatigue) questionnaireGeoffrey Cheminet, Anne Corbasson, Marie Charmettan, et al.
British Journal of Haematology|November 10, 2022
Safety of coronavirus disease 2019 vaccines in 213 adult patients with sickle cell diseaseLaure Joseph, Anne Corbasson, Sandra Manceau, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 2, 2025
Central-venous-catheter-related bloodstream infections in adult patients with sickle cell disease: a retrospective, two-centre studyMatthieu Holub, David Lebeaux, Patrick Grohs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 2023
Nirmatrelvir and Ritonavir Combination in COVID-19 Patients With Advanced Chronic Kidney DiseaseEmmanuel Lafont, Damien Blez, Marc-Antoine Bildan, et al.
La Revue De Medecine Interne|March 19, 2021
[Abnormal urine color assessment: The urine wheel]Edouard Flamarion, Constance Reichert, Caroline Sayegh, et al.
Internal and Emergency Medicine|June 29, 2018
Extreme hypomagnesemia: characteristics of 119 consecutive inpatientsGeoffrey Cheminet, Gabrielle Clain, Anne-Sophie Jannot, et al.
American Journal of Hematology|December 9, 2021
Risk factors for severe COVID-19 in hospitalized sickle cell disease patients: A study of 319 patients in FranceJean-Benoît Arlet, François Lionnet, Djamal Khimoud, et al.
Pageof 3